Client Story
How PHM helped Laura access innovative treatments to manage her stage 4 colorectal cancer.
Laura, a 46-year-old lawyer and busy mother with a passion for horseback riding, was diagnosed with stage 4 colorectal cancer that had spread to her liver. Despite undergoing surgery and chemotherapy, her cancer continued to progress.
Determined to explore new options, Laura turned to Private Health Management to discover new options, embracing a proactive approach in her health journey.
PHM conducted comprehensive molecular profiling, identifying Laura’s cancer as HER2-positive, a crucial discover that opened the door to HER2-targeting therapies. This treatment stabilized her disease for eight months and allowed her to continue her active lifestyle.
As her disease progressed, PHM’s Personal Care Team guided her through a series of advanced therapies to maintain stability.
These included targeted therapies, cancer vaccines, and novel treatment combinations. Laura was among the first patients to receive a cutting-edge form of targeted radioactive therapy.
Laura lived with stage 4 colorectal cancer for nearly eight years, far exceeding typical outcomes for her diagnosis. Her journey illustrates PHM’s steadfast commitment to implementing precision medicine and advanced therapeutic strategies, providing patients with care that extends life and ensures ongoing support.
Learn more insights about improving patient care in our Cancer Survivability whitepaper.
Discover our Why Wall
